By Associated Press July 2, 2009 | Comments (0)
Recs
Shares of some top biotechnology companies were down at the close of trading:
Amgen fell $1.29 or 2.4 percent, to $51.47.
Biogen Idec fell $1.77 or 3.8 percent, to $45.00.
Celgene fell $1.37 or 2.8 percent, to $46.73.
Gilead Sciences fell $.93 or 2.0 percent, to $45.90.
Read/Post Comments (0) | Recommend This Article (0) Recommended 0 Times
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.
Your Fool username will be displayed with your comment. Please be respectful with your comments. Review our Fool's Rules.
Javascript is required to comment on Fool articles.
DocumentId: 933963, ~/Articles/ArticleHandler.aspx, 11/8/2009 7:24:56 PM
Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.
By The Motley Fool
Rate base: The rate base is the amount of assets a utility is allowed to include in the calculation of the rates charged to users. Rate increases must be approved by a state utility board. The approved rate is normally based on a target return on the allowed rate base.
Want to learn more or edit this definition? Click here to read more!
Terms & Conditions
RSS Headlines
Fool UK